NGX Bio, Inc. — Form D
NGX Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-02. The offering totals $600K, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-09-02
- Form: D
- Accession: 0001192482-15-000384
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $300K
- Remaining: $300K
- Investors: 7
- Date of first sale: 2015-08-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-246876
Issuer
- Name: NGX Bio, Inc.
- CIK: 0001635908
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 739 BRYANT STREET, SAN FRANCISCO, CA, 92107
- Phone: 617-680-6841
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexi Andreev | Director | San Francisco, CA |
| Amit Kumar | Director | New York, NY |
| Dmitri Petrov | Director | Mountain View, CA |
| Sam Tolkoff | Director | San Francisco, CA |
| Sam Tolkoff | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More